HK1038754A1 - 增加主要組織相容性複雜級別i限制抗原顯示的成分及方法 - Google Patents

增加主要組織相容性複雜級別i限制抗原顯示的成分及方法

Info

Publication number
HK1038754A1
HK1038754A1 HK02100178.2A HK02100178A HK1038754A1 HK 1038754 A1 HK1038754 A1 HK 1038754A1 HK 02100178 A HK02100178 A HK 02100178A HK 1038754 A1 HK1038754 A1 HK 1038754A1
Authority
HK
Hong Kong
Prior art keywords
enhancement
compositions
methods
major histocompatibility
histocompatibility complex
Prior art date
Application number
HK02100178.2A
Other languages
English (en)
Inventor
Laus Reiner
Hakim Itzhak
Vidovic Damir
Original Assignee
Dendreon Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dendreon Corp filed Critical Dendreon Corp
Publication of HK1038754A1 publication Critical patent/HK1038754A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4615—Dendritic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/462—Cellular immunotherapy characterized by the effect or the function of the cells
    • A61K39/4622—Antigen presenting cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A61K39/464499—Undefined tumor antigens, e.g. tumor lysate or antigens targeted by cells isolated from tumor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK02100178.2A 1998-12-14 2002-01-10 增加主要組織相容性複雜級別i限制抗原顯示的成分及方法 HK1038754A1 (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11232498P 1998-12-14 1998-12-14
PCT/US1999/029724 WO2000035949A1 (en) 1998-12-14 1999-12-14 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation

Publications (1)

Publication Number Publication Date
HK1038754A1 true HK1038754A1 (zh) 2002-03-28

Family

ID=22343285

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02100178.2A HK1038754A1 (zh) 1998-12-14 2002-01-10 增加主要組織相容性複雜級別i限制抗原顯示的成分及方法

Country Status (7)

Country Link
EP (1) EP1141007B1 (zh)
JP (1) JP2002532514A (zh)
AU (1) AU775767B2 (zh)
CA (1) CA2353816C (zh)
HK (1) HK1038754A1 (zh)
NZ (1) NZ512807A (zh)
WO (1) WO2000035949A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7148324B1 (en) 1998-12-14 2006-12-12 Dendreon Corporation Compositions and methods for enhancement of major histocompatibility complex class I restricted antigen presentation
US7030228B1 (en) 1999-11-15 2006-04-18 Miltenyi Biotec Gmbh Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby
PT1272633E (pt) * 2000-03-30 2011-06-27 Dendreon Corp Composições e métodos para imunoterapia baseada em células dendríticas
FR2955773B1 (fr) 2010-02-01 2017-05-26 Commissariat A L'energie Atomique Complexe moleculaire de ciblage des antigenes vers les cellules presentatrices d'antigene et ses applications pour la vaccination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL296382A1 (en) * 1991-02-02 1993-11-02 Nika Health Products Ltd Li Li Artificial membrane beads containing functionally active peptides responsible for fusion as a drug administering system
US5837533A (en) * 1994-09-28 1998-11-17 American Home Products Corporation Complexes comprising a nucleic acid bound to a cationic polyamine having an endosome disruption agent
WO1996012009A2 (en) * 1994-10-14 1996-04-25 Tykocinski Mark L Methods for engineering antigen-presenting cells

Also Published As

Publication number Publication date
EP1141007B1 (en) 2013-05-15
WO2000035949A1 (en) 2000-06-22
AU2053800A (en) 2000-07-03
JP2002532514A (ja) 2002-10-02
CA2353816C (en) 2010-06-01
CA2353816A1 (en) 2000-06-22
AU775767B2 (en) 2004-08-12
EP1141007A1 (en) 2001-10-10
NZ512807A (en) 2003-10-31

Similar Documents

Publication Publication Date Title
IL136972A0 (en) Novel anti-estrogenic steroids and associated pharmaceutical compositions and methods of use
AU2001255196A1 (en) Compositions and methods for enhancing immunogenicity of antigens
HUP0103598A3 (en) Compositions and methods for wt1 specific immunotherapy
AU3983201A (en) Compositions and methods for the early diagnosis of ovarian cancer
AU3491001A (en) Compositions and methods for the early diagnosis of ovarian cancer
AU2230199A (en) Vaccine compositions and methods of modulating immune responses
AU6039798A (en) Device for determining composition and structure of objects
IL149140A0 (en) Compositions and methods for determining interactions of mitochondrial components
AU5383298A (en) Compositions and methods for enhancement of dehydroepiandrosterone
NO993694L (no) Sylfonylurea- og adjuvansbaserte faste blandinger
AU2001294820A1 (en) Methods for in vivo reduction of free radical levels and compositions useful therefor
HUP0104822A3 (en) Clathrates of dehydroepiandrosterone and corresponding pharmaceutical compositions
IL132094A0 (en) Methods and compositions for treatment of ovarian cancer
HK1038754A1 (zh) 增加主要組織相容性複雜級別i限制抗原顯示的成分及方法
AU1615701A (en) Compositions and methods for regulating tumor-associated antigen expression
IL137836A0 (en) Methods and compositions for diagnosis of hepatoma
EP1062320A4 (en) METHODS AND COMPOSITIONS FOR THE SELECTIVE DEVELOPMENT OF T GAMMA / DELTA T CELLS
EP1063891A4 (en) METHODS FOR INCREASED ANTIQUE PRESENTATION ON ANTIQUE-PRESENTING CELLS AND PREPARATIONS PRODUCED BY THEM
AU2002254431A1 (en) Antibodies against autoantigens of primary biliary cirrhosis and methods of making and using them
AU8513698A (en) Methods and compositions for designing vaccines
AU3241400A (en) Compositions and methods using complexes of calreticulin and antigenic molecules
AU5883300A (en) Compositions and methods for the quantification of sterol biosynthetic flux
AU2401001A (en) Means of stabilizing compositions and reagents
EP1071325A4 (en) COMPOSITIONS AND METHODS FOR SPECIFIC VACCINATION OF THE ANTIGEN
AU1471300A (en) Compositions and methods for treatment of cancer